實驗要點及說明：

1．本方法適用于貼壁細(xì)胞培養(yǎng)，而不適用于懸浮細(xì)胞培養(yǎng)，懸浮細(xì)胞可使用滴片法； 

2．所使用的蓋玻片應(yīng)該為玻璃**，并經(jīng)過鉻酸洗液處理； 

3．蓋玻片非常薄，易碎，取放蓋玻片時動作要輕； 

4．如果需要更多生長狀態(tài)一致的細(xì)胞，可以使用較大的培養(yǎng)皿，但不宜過大，以避免培養(yǎng)液的浪費和增加污染機率； 

5．如果細(xì)胞貼壁生長能力較差，可將蓋玻片在0.5%多聚賴氨酸溶液中浸泡5-10分鐘并自然晾干。

培養(yǎng)方法

傳代方法 將舊培養(yǎng)液吸除，PBS清洗兩遍后，加入6mL（/100mm皿）胰酶，在顯微鏡下觀察，期間禁止搖晃培養(yǎng)皿，細(xì)胞剛有脫落時，則吸除大部分胰酶，留約0.5mL，移至培養(yǎng)箱消化，約2min取出。傳代用12mL CM1-1培養(yǎng)液終止消化，輕輕吹打均勻細(xì)胞，后可分3~6皿培養(yǎng)；

生長條件 37℃，5%CO2，CM1-1培養(yǎng)液。CM1-1培養(yǎng)液：90%DMEM-H+10%FBS。DMEM-H：DMEM高糖培養(yǎng)液，含谷氨酰胺，含丙酮酸鈉。

存儲條件 凍存則用6mL凍存液（90%FBS+10%DMSO）終止消化，吹打均勻，分為6支凍存管，用程序降溫盒于-80℃凍存，過夜轉(zhuǎn)移至液氮中保存。

我司常期代理ATCC Acris  abcam  cst  Biorbyt  santa  Novus  sigma  lifespan  NEB  roche  ABI  R&D millipore   BD  Qiagen Cayman  Jackson Life  GeneTex   Bio-Rad DSHB  tocris   peprotech 等品牌；部分產(chǎn)品現(xiàn)貨，超低比價，貨期短，價格優(yōu)，公司產(chǎn)品僅用于科研售后齊全。

培養(yǎng)操作步驟 ：

1．用蓋片鑷將蓋玻片自75%乙醇中取出，用無菌絲綢布擦拭干凈，不要用紗布； 

2．將蓋玻片輕輕放入6孔培養(yǎng)板（每孔一片）或培養(yǎng)皿中（每個平皿可放置2-3片）； 

3．在距離紫外燈直射范圍內(nèi)20-30 厘米處照射2-3小時； 

4．將經(jīng)過計數(shù)的細(xì)胞懸浮液移入培養(yǎng)板中，使蓋玻片完全浸在培養(yǎng)液中； 

5．將培養(yǎng)板在5% CO2水浴孵箱中37℃孵育2-3天，當(dāng)貼壁細(xì)胞生長至覆蓋培養(yǎng)板底部2/3面積時，將培養(yǎng)板取出，用蓋片鑷輕輕取出蓋玻片，用蒸餾水漂洗后即可進行快速固定以及細(xì)胞化學(xué)檢測。 

細(xì)胞培養(yǎng)方法：

1、細(xì)胞傳代：細(xì)胞密度達(dá)到80-90%時即可傳代

①棄去培養(yǎng)上清，用PBS或生理鹽水清洗1-2次；

②加入2ml0.25%胰酶（T25瓶），使胰酶覆蓋整個瓶或皿，蓋好放入培養(yǎng)箱消化；

③1-2min后，顯微鏡下觀察細(xì)胞，若大部分細(xì)胞回縮且有少量細(xì)胞脫落，輕輕吹打下確認(rèn)消化情況后加入完全培養(yǎng)基終止消化；若細(xì)胞還是貼壁，放回培養(yǎng)箱繼續(xù)消化至可以輕輕吹打下為止；

④將細(xì)胞懸液1000RPM左右條件下離心4min，棄上清；

⑤用新鮮培養(yǎng)基重懸后加入培養(yǎng)瓶或皿中，T25培養(yǎng)瓶加6-8ml培養(yǎng)基；

⑥懸浮細(xì)胞直接離心收集，細(xì)胞沉淀重懸后分到新培養(yǎng)瓶中。

2、細(xì)胞復(fù)蘇：

①將凍存管在37℃溫水中快速搖晃融化，時間1min左右，加入4-5ml培養(yǎng)基混勻。

②在1000RPM左右條件下離心4min，棄上清,加1-2ml培養(yǎng)基吹勻，將細(xì)胞懸液加入培養(yǎng)瓶中，補加適量培養(yǎng)基。

3、細(xì)胞凍存：待細(xì)胞生長狀態(tài)良好時進行細(xì)胞凍存保種

①棄去培養(yǎng)上清，用PBS或生理鹽水清洗1-2次，加入1mL 0.25%胰蛋白酶（T25瓶）

②1-2min后，顯微鏡下觀察細(xì)胞，大部分細(xì)胞回縮且有少量細(xì)胞脫落，輕輕吹打下確認(rèn)消化情況后加入完全培養(yǎng)基終止消化；

③將細(xì)胞懸液1000RPM左右條件下離心4min，棄上清，加1ml凍存液重懸細(xì)胞；

④將凍存管放入程序降溫盒，放入-80℃冰箱，4小時后將凍存管轉(zhuǎn)入液氮罐儲存。

Subunit : Interacts with homodimeric PDGFA, PDGFB and PDGFC, and with heterodimers formed by PDGFA and PDGFB. Monomer in the absence of bound ligand. Interaction with dimeric PDGFA, PDGFB and/or PDGFC leads to receptor dimerization, where both PDGFRA homodimers and heterodimers with PDGFRB are observed. Interacts (tyrosine phosphorylated) with SHB (via SH2 domain). Interacts (tyrosine phosphorylated) with SHF (via SH2 domain). Interacts (tyrosine phosphorylated) with SRC (via SH2 domain). Interacts (tyrosine phosphorylated) with PIK3R1. Interacts (tyrosine phosphorylated) with PLCG1 (via SH2 domain). Interacts (tyrosine phosphorylated) with CRK, GRB2 and GRB7. Interacts with human cytomegalovirus/HHV-5 envelop glycoprotein B/gB.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Note=The activated receptor is rapidly internalized and degraded.

Tissue Specificity : Detected in platelets (at protein level). Widely expressed. Detected in brain, fibroblasts, smooth muscle, heart, and embryo. Expressed in primary and metastatic colon tumors and in normal colon tissue.

Post-translational modifications : N-glycosylated.

Ubiquitinated, leading to its degradation (Probable).

Autophosphorylated on tyrosine residues upon ligand binding. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit. Phosphorylation at Tyr-731 and Tyr-742 is important for interaction with PIK3R1. Phosphorylation at Tyr-720 and Tyr-754 is important for interaction with PTPN11. Phosphorylation at Tyr-762 is important for interaction with CRK. Phosphorylation at Tyr-572 and Tyr-574 is important for interaction with SRC and SRC family members. Phosphorylation at Tyr-988 and Tyr-1018 is important for interaction with PLCG1.

DISEASE : Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome.

Defects in PDGFRA are a cause of gastrointestinal stromal tumor (GIST) [MIM:606764]. Note=Mutations that cause constitutive activation of PDGFRA may be a cause of gastrointestinal stromal tumor (GIST).

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. CSF-1/PDGF receptor subfamily.

Contains 5 Ig-like C2-type (immunoglobulin-like) domains.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P16234.1

PDGFR-α是膜受體，具有酪氨酸酶的活性，與其配體PDGF結(jié)合后激活與細(xì)胞增殖有關(guān)的酶及基因。 PDGFR亦表達(dá)于上皮、內(nèi)皮細(xì)胞，前列腺、皮膚、腎小球等上皮細(xì)胞均有PDGFR表達(dá). 亦有學(xué)者報道血小板源性生長因子受體α抗體在細(xì)胞胞漿胞膜、胞核都有不同的表達(dá)還有人認(rèn)為：PDGF及其受體一般表達(dá)于浸潤病變組織的炎癥細(xì)胞附近，組織缺血損傷、腎小球高壓、因素作用、炎癥細(xì)胞浸潤、實質(zhì)細(xì)胞活化等導(dǎo)致PDGFR表達(dá)增強。

英文名稱  Anti-Phospho-PDGFRA(Tyr572)/PDGFRB(Tyr579)  

中文名稱  磷酸化血小板源性生長因子受體α

別    名  PDGFRA(phospho Y572); PDGF Receptor alpha(Tyr849)/PDGF Receptor beta (Tyr857); Platelet–dirived growth factor receptor-alpha; Alpha platelet derived growth factor receptor; CD 140a; CD140a; CD140a antigen; MGC74795; PDGF alpha chain; PDGF R alpha; PDGFR 2; PDGFR A; PDGFR alpha; PDGFR2; PDGFRA; Platelet derived growth factor receptor 2; Platelet derived growth factor receptor alpha; Platelet derived growth factor receptor alpha polypeptide; PGFRA_HUMAN.

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg
DMEM基礎(chǔ)培養(yǎng)基肌原纖蛋白2檢測試劑盒鋅 CP，99%疊氮化四丁基銨  95%

抗組蛋白(H2A-H2B)-DNA抗體；抗二聚體-DNA抗體檢測試劑盒鋅粉 AR,99%十二烷基硫酸鈉 CP

抗生長抗體檢測試劑盒鋅 AR，99%十二烷基硫酸鈉 Ph. Eur，USP級，92%

基質(zhì)相互作用分子2檢測試劑盒鋅粉 SP十二烷基硫酸鈉 AR，92.5-100.5%

抑制性IgG受體檢測試劑盒鋅粒 SP十二烷基硫酸鈉 97%，電泳

EB病Rta蛋白IgG抗體檢測試劑盒對氨基苯乙 98%十二烷基硫酸鈉 99.0%，超純級

黃???病IgG抗體檢測試劑盒苯甲酰 98%十二烷基硫酸鈉 ACS